Companies related to Cardiomyocytes

Ncardia believes that human stem cell (iPSCs) technologies will bring better therapies to patients faster.

The Power of Human Biology: Leveraging our human iPSC technology to revolutionize scientific research and cell therapy.

Our proprietary human cell and engineered tissue organoid models allow the simulation of health and disease in the dish.

Pre-plated, human iPSC-derived microOrgans for toxicology and drug discovery research